Haemonetics

HAE64

$88.92arrow_drop_down0.38%-$0.34

HAE64

$88.92

arrow_drop_down0.38%-$0.34

Performance History

Key Stats
Open	$91.37
Prev. Close	$90.75
EPS	2.37
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	88.68	91.75
52 Week Range	67.72	97.97

Ratios







EPS	2.37

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Haemonetics (HAE)

Haemonetics Corp (HAE) is a leading global provider of blood and plasma supplies and services. With a rich history dating back to its founding in 1971, the company has continuously innovated and grown to become a trusted name in the healthcare industry. Today, Haemonetics Corp is known for its cutting-edge medical devices and software solutions that improve the safety and efficiency of blood management.

One of the key products offered by Haemonetics Corp is the TEG Thrombelastography Analyzer System, a state-of-the-art diagnostic tool that provides real-time information on a patient's clotting status. This system is widely used in hospitals and blood centers to assist healthcare professionals in making critical treatment decisions. The TEG system has been praised for its accuracy and reliability, and has helped save countless lives by enabling quicker and more informed medical interventions.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Christopher A. Simon
Headquarters: Boston
Employees: 3034
Exchange: NYSE

Keep an eye on Haemonetics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Haemonetics's (HAE) price per share?

The current price per share for Haemonetics (HAE) is $88.92. The stock has seen a price change of -$0.34 recently, indicating a -0.38% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Haemonetics (HAE)?

For Haemonetics (HAE), the 52-week high is $97.97, which is 10.18% from the current price. The 52-week low is $67.72, the current price is 31.31% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Haemonetics (HAE) a growth stock?

Haemonetics (HAE) has shown an average price growth of -6.8% over the past three years. It has received a score of 73 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Haemonetics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Haemonetics (HAE) stock price performance year to date (YTD)?

As of the latest data, Haemonetics (HAE) has a year-to-date price change of 4.44%. Over the past month, the stock has experienced a price change of 17.09%. Over the last three months, the change has been 18.8%. Over the past six months, the figure is -7.11%. Looking at a longer horizon, the five-year price change stands at -25.35%.

help

Is Haemonetics (HAE) a profitable company?

Haemonetics (HAE) has a net income of $117.56M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 51.68% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 16.44% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.31B, with a revenue growth rate of 12.01%, providing insight into the company's sales performance and growth. The gross profit is $676.54M. Operating income is noted at $164.88M. Furthermore, the EBITDA is $274.9M.

help

What is the market capitalization of Haemonetics (HAE)?

Haemonetics (HAE) has a market capitalization of $4.47B. The average daily trading volume is 89.02, indicating the stock's liquidity and investor engagement.